Evidence map›Paper›PMID 36823237›Full record

ArticleScientific reports2023

Targeted delivery of paclitaxel drug using polymer-coated magnetic nanoparticles for fibrosarcoma therapy: in vitro and in vivo studies.

Rusul Al-Obaidy, Adawiya J Haider, Sharafaldin Al-Musawi, Norhana Arsad

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Nanocarriers for cutting-edge cancer immunotherapies.Journal of translational medicine · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Rusul Al-ObaidyApplied Sciences Department/Laser Science and Technology Branch, University of Technology, Baghdad, Iraq.
Adawiya J HaiderApplied Sciences Department/Laser Science and Technology Branch, University of Technology, Baghdad, Iraq.
Sharafaldin Al-MusawiCollege of Food Sciences, Al-Qasim Green University, Babylon, Iraq.
Norhana ArsadPhotonics Technology Laboratory, Department of Electrical, Electronic and Systems Engineering, Faculty of Engineering and Built Environment, Universiti Kebangsaan Malaysia UKM, 43600, Bangi, Malaysia. noa@ukm.edu.my.
University of Technology - Iraq · IQMinistry of Higher Education and Scientific Research · IQNational University of Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibrosarcoma is a rare type of cancer that affects cells known as fibroblasts that are malignant, locally recurring, and spreading tumor in fibrous tissue. In this work, an iron plate immersed in an aqueous solution of double added deionized water, supplemented with potassium permanganate solution (KMnO

Indexed as

Antineoplastic AgentsFibrosarcomaMagnetite NanoparticlesNanoparticlesAnimalsCell Line, TumorFolic AcidMicePaclitaxelPolyethylene GlycolsPolymersAntineoplastic AgentsFolic AcidMagnetite NanoparticlesPaclitaxelpoly(ethylene glycol)-folatePolyethylene GlycolsPolymers

Identifiers

PMID36823237
PMCPMC9950487
OpenAlexW4321615251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.